NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
BASE SHELF PROSPECTUS ACCESSIBLE AND PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE ON SEDAR+
BRISBANE, Australia, April 25, 2024 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce that it is commencing a marketed offering (the “Offering”) of units (the “Units”) of the Company. Each Unit will consist of one ordinary share of the Company (a “Common Share”) and one ordinary share purchase warrant (a “Warrant”).
The Units will be offered under the amended and restated base shelf prospectus of the Company receipted on January 10, 2024 (the “Base Shelf Prospectus”), as supplemented by a prospectus supplement (the “Supplement”) to be prepared and filed in each of the provinces and territories of Canada other than Québec (collectively, the “Jurisdictions”), in the United States pursuant to available exemptions from the registration requirements under applicable United States securities laws, and in such other jurisdictions outside of Canada and the United States which are agreed to by the Company and the Underwriter (as defined below).
The total size of the Offering as well as certain other terms of the Units and the Warrants (including the term and the exercise price of each Warrant) will be determined in the context of the market at the time of pricing. There can be no assurance as to whether or when the Offering may be completed, or as to the size or terms of the Offering. The closing of the Offering remains subject to market and other customary conditions, including but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange (the “TSXV”).
PI Financial Corp. is acting as sole underwriter and bookrunner for the Offering (the “Underwriter”).
The Company intends to grant the Underwriter an option (the “Over-Allotment Option”) to cover over-allotments and for market stabilization purposes, exercisable at any time up to 30 days subsequent to the closing of the Offering, to purchase up to an additional 15.0% of the Units, pursuant to the Offering on the same terms and conditions of the Offering. The Over-Allotment Option will be exercisable to acquire Units, Common Shares and/or Warrants (or any combination thereof) at the discretion of the Underwriter.
The Company will pay the Underwriter a cash commission equal to 7.0% of the gross proceeds of the Offering, including proceeds received from the exercise of the Over-Allotment Option. In addition, the Company will issue the Underwriter compensation warrants to purchase up to 7.0% of the aggregate number of Units issued pursuant to the Offering, including any Units issued upon exercise of the Over-Allotment Option (the “Compensation Warrants”). Each Compensation Warrant shall entitle the Underwriter to purchase one Unit at the Offering Price at any time on or before the date which is 48 months following closing of the Offering.
The net proceeds of the Offering are expected to be used primarily to strengthen the Company's financial position and provide liquidity to ?finance ongoing operations, including, in particular, the Company’s expenses incurred, and expected to be ?incurred, in connection with the Company’s research and development objectives, and for working capital and general corporate purposes.
Access to the Base Shelf Prospectus, the Supplement, and any amendment to the documents is provided in accordance with securities legislation relating to procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment. The Base Shelf Prospectus is, and the Supplement will be, accessible on SEDAR+ at www.sedarplus.ca.
An electronic or paper copy of the Base Shelf Prospectus, the Supplement (when filed), and any amendment to the documents may be obtained, without charge, from PI Financial Corp, ?3401 – 40 King St Street, Toronto, ON, Canada, M5H 3Y2, by email to [email protected] attention: PI Syndication and by providing the contact with an email address or address, as applicable. The Base Shelf Prospectus contains and the Supplement will contain, important detailed information about the Company and the proposed Offering. Prospective investors should read the Supplement (when filed) and the Base Shelf Prospectus and the other documents the Company has filed on SEDAR+ before making an investment decision.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
About GMG
GMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, ‘tuneable’ and low/no contaminant graphene suitable for use in clean-technology and other applications.
The Company’s present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning (“HVAC-R”) coating (or energy-saving coating), lubricants and fluids.
In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries (“G+AI Batteries”).
GMG’s 4 critical business objectives are:
Produce Graphene and improve/scale cell production processes
Craig Nicol, Chief Executive Officer and Managing Director of the Company at [email protected], +61 415 445 223
Leo Karabelas at Focus Communications Investor Relations, [email protected], +1 647 689 6041
www.graphenemg.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.
This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends”, “expects” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or will “potentially” or “likely” occur. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation, the Company's ability to complete the Offering on the terms announced or at all, the use of the net proceeds of the Offering, and the receipt of all necessary approvals, including the approval of the TSXV, the Company’s collaboration with the University of Queensland, and the Company’s objectives, focus, goals or future plans.
Such forward-looking statements are based on a number of assumptions of management, including, without limitation, assumptions regarding the ability of the Company to obtain all necessary approvals for the Offering, the ability of the Underwriter to secure interest in the Offering, the ability of the Company and the Underwriter to negotiate a definitive agreement with respect to the Offering, the ability of the Company to achieve the expected results of its products in research and development, that the Company will be able to research, develop and produce certain products as anticipated, that the Company will be able to engage third parties and develop relationships to assist in the development, that the Company and the University of Queensland will continue to progress research and development of the G+AI Batteries, distribution and sale of its products, and assumptions regarding the completion of the Offering and the timing thereof. Additionally, forward-looking information involve a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the Offering will not be completed on the timetable anticipated or at all, the use of proceeds from the Offering will differ from management’s current expectations, the engagement of the Underwriter in connection with the Offering will not continue as expected, the Company will not obtain all necessary approvals, including the approval of the TSXV and applicable securities regulatory authorities, the Company will not be able to use its products as expected or the performance, safety profile and production and maintenance requirements of the Company’s products will not be consistent with management’s expectations, the impact of the Company’s products will not be consistent with management’s expectations, the Company will not be able to research, develop and produce certain products, that the Company’s collaboration with the University of Queensland will not continue as currently expected by management, the Company will not be successful in engaging third parties and developing relationships to assist in the development, distribution and sale its products, public health crises may adversely impact the Company’s business and the ability of the Company to develop its products, risks relating to the extent and duration of the conflict in the Middle-East and Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading “Risk Factors” in the Company’s annual information form dated October 12, 2023 available for review on the Company’s profile at www.sedarplus.com.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.